Stephen M. Langley, MD, Medical Director and Chief of Pediatric Cardiac Surgery at Driscoll Children’s Hospital

In this episode, Dr. Joseph G. Cacchione, CEO of Jefferson Health, shares how lessons from coaching, clinical practice, and personal experiences have shaped his leadership philosophy. He discusses the emotional core of healthcare, the importance of humility, and how strong relationships and frontline support are key to resilient organizations.

This episode features Dr. Jaideep Banerjee, Director of Global Clinical & Medical Affairs at Smith+Nephew, discussing the challenges of chronic wound care, the importance of standardized evidence-based practices, and insights from his recent large-scale study on enzymatic debridement. Dr. Banerjee shares strategies for improving patient outcomes, reducing costs, and building a strong foundation for long-term healing.This episode is sponsored by Smith+Nephew.Important Safety InformationIndication: Collagenase SANTYL Ointment (“SANTYL”) is indicated for debriding chronic dermal ulcers and severely burned areas. Contraindications: SANTYL is contraindicated in patients who have shown local or systemic hypersensitivity to collagenase. Warnings and Precautions: The optimal pH range of collagenase is 6 to 8. Higher or lower pH conditions will decrease the enzyme’s activity and appropriate precautions should be taken. The enzymatic activity is also adversely affected by certain detergents, and heavy metal ions such as mercury and silver which are used in some antiseptics. As such, the wound should be properly cleansed prior to application of SANTYL. Debilitated patients should be closely monitored for systemic bacterial infections because of the theoretical possibility that debriding enzymes may increase the risk of bacteremia. A slight transient erythema has been noted occasionally in the surrounding tissue, particularly when SANTYL was not confined to the wound. SANTYL is not indicated for wound closure. Discontinue use of SANTYL after granulation tissue is well-established. Adverse Reactions: No allergic sensitivity or toxic reactions have been noted in clinical use when used as directed. The risk information provided herein is not comprehensive. To see the complete Prescribing Information, please see the FDA-approved product labeling, here: https://www.santyl.com/pdf/SANTYL-PI.pdf. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

In this episode, Dr. Myron Rolle, Pediatric Neurosurgeon at Nemours Children’s Hospital, shares his inspiring journey from professional football to medicine. He discusses the impact of culture and resilience in pediatric care, advances in neurosurgery, and his advocacy for brain injury prevention and youth empowerment.

In this episode, Dan Kueter, CEO of UnitedHealthcare's Employer & Individual business, talks about new tools like the UHC Store, the impact of AI on healthcare navigation, and how employers and members are adapting to rising costs and evolving therapies.

In this episode, Doug Lang, Vice President of Strategic Accounts at Health Recovery Solutions, shares key strategies for building and scaling hospital-at-home programs. He discusses leadership alignment, financial sustainability, and how expanding eligibility can transform patient care and system capacity.This episod is sponsored by Health Recovery Solutions.

In this episode, Dr. Marty Makary, Commissioner of Food and Drugs at the FDA, joins the podcast to discuss rebuilding public trust in healthcare, modernizing drug approval processes, improving the nation’s food supply, and addressing current concerns surrounding Tylenol and vaccines. He also highlights promising innovations in treatments for autism, diabetes, cancer, and PTSD.

Ashok Chennuru, Chief Data & Digital Transformation Officer at Elevance Health, discusses proactive care and strategies to enhance the customer experience. He highlights the importance of human-centered healthcare, personalizing experiences through AI, and offers advice for emerging leaders navigating the future of health transformation.

In this episode, Dr. Corey Anderson, Dentist and Practice Owner at Affordable Dentures & Implants in West Virginia, shares insights on workforce challenges, patient expectations, and the growing role of digital technology and AI in dentistry. He also reflects on leadership, continuing education, and why servant leadership is key to the profession’s future.

In this episode, Amy King, Chief Human Resources Officer at Denver Health, shares her insights on workforce trends, leadership development, and building a supportive culture. She discusses retention strategies, the importance of empathy and accountability in evolving healthcare leadership, and much more.

Stephen M. Langley, MD, Medical Director and Chief of Pediatric Cardiac Surgery at Driscoll Children’s Hospital, discusses the future growth of pediatric care, including expanding access to care in the coming years. He highlights the importance of establishing a strong organizational culture, known as “The Driscoll Way,” to build high-performing teams. Dr. Langley also emphasizes the “best care model,” which ensures patients receive the highest degree of attention at every stage of care, and shares what excites him most about the future of healthcare.